Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS.
The formation of acquired drug resistance is a major reason for the failure of anti-cancer therapies after initial response. Here, we introduce a novel model of acquired oxaliplatin resistance, a sub-line of the non-MYCN-amplified neuroblastoma cell line SK-N-AS that was adapted to growth in the pre...
Saved in:
Similar Items
-
Multi-Pathway Study for Oxaliplatin Resistance Reduction
by: Tong Ye, et al.
Published: (2025-03-01) -
Revealing the role of increased SK3 expression in sulfonylurea resistance triggered by prolonged exposure
by: Jung Gyu Park, et al.
Published: (2025-06-01) -
Investigating the cytotoxic effect of aqueous extract of Peganum harmala on oxaliplatin-resistant HCT116 cell line and evaluating BAX gene expression
by: Zahra Salimizadeh, et al.
Published: (2025-03-01) -
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
by: Reio Ueta, et al.
Published: (2025-07-01) -
Artesunate inhibits proliferation and promotes apoptosis and autophagy of nephroblastoma cell line SK-NEP-1
by: WEI Jianxin, FANG Yanle, LU Yubo, GAO Yuguang, LANG Xing, LI Jingtao, MA Xinsheng
Published: (2025-04-01)